Skip to main content

Advertisement

Log in

Role of Brain Biomarker in Predicting Clinical Outcome in Hypertensive Cerebrovascular Ischemic Stroke

  • Original Article
  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

This study was undertaken to evaluate the role of serum neuron specific enolase (NSE) in prediction of disability and neurological worsening in hypertensive ischemic cerebrovascular stroke. 80 hypertensive ischemic stroke patients diagnosed by a neurologist as per WHO definition along with radiological findings suggestive of cerebrovascular stroke and differentiating from hemorrhagic stroke and 60 controls having essential hypertension coming to hospital because of regular checkup or headache but with no neurological disease were included in the study. Neurological disability was assessed by NIHSS at the time of admission (within 72 h from the onset of stroke) and on 7th day after admission and cases were categorized into mild, moderate and severe disability. Venous blood samples were drawn within 72 h from the onset of symptoms. The samples were processed as per the laboratory protocol. The serum NSE samples were analyzed using an enzyme immunoassay based on the sandwich technique. We observed raised serum NSE in hypertensive ischemic stroke (17.4 ± 5.4 ng/ml) with significant association between different hypertensive groups than in hypertensive controls (9.1 ± 0.75 ng/ml). Greater degree of disability was observed in hypertensive stroke patients with raised serum NSE and hypertensive patients with mean serum NSE level of 22.9 ± 3.6 ng/ml and dyslipidemia had greater probability of neurological worsening as compared to those with mean serum NSE level of 12.7 ± 1.2 ng/ml. Serum NSE levels can serve as a peripheral indicator of neuronal damage and assist in the prediction of disability and clinical outcome in hypertensive cerebrovascular ischemic stroke patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ohira T, Shahar E, Chambless LE, Rosamond WD, Mosley TH, Folsom AR. Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study. Stroke J Cereb Circ. 2006;37(10):2493–8.

    Article  CAS  Google Scholar 

  2. Al-Sarraf H, Philip L. Effect of hypertension on the integrity of blood brain and blood CSF barriers, cerebral blood flow and CSF secretion in the rat. Brain Res. 2003;975(1–2):179–88.

    Article  CAS  PubMed  Google Scholar 

  3. Poulet R, Gentile MT, Vecchione C, Distaso M, Aretini A, Fratta L, et al. Acute hypertension induces oxidative stress in brain tissues. J Cereb Blood Flow Metab. 2006;26(2):253–62.

    Article  CAS  PubMed  Google Scholar 

  4. Ueno M, Sakamoto H, Liao Y-J, Onodera M, Huang C-L, Miyanaka H, et al. Blood-brain barrier disruption in the hypothalamus of young adult spontaneously hypertensive rats. Histochem Cell Biol. 2004;122(2):131–7.

    Article  CAS  PubMed  Google Scholar 

  5. Ishida H, Takemori K, Dote K, Ito H. Expression of glucose transporter-1 and aquaporin-4 in the cerebral cortex of stroke-prone spontaneously hypertensive rats in relation to the blood-brain barrier function. Am J Hypertens. 2006;19(1):33–9.

    Article  CAS  PubMed  Google Scholar 

  6. Gorelick PB, Aiyagari V. The management of hypertension for an acute stroke: what is the blood pressure goal? Curr Cardiol Rep. 2013;15(6):366.

    Article  PubMed  Google Scholar 

  7. Chalela JA, Kidwell CS, Nentwich LM, Luby M, Butman JA, Demchuk AM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007;369(9558):293–8.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Sotak CH. The role of diffusion tensor imaging in the evaluation of ischemic brain injury—a review. NMR Biomed. 2002;15(7–8):561–9.

    Article  PubMed  Google Scholar 

  9. Meric E, Gunduz A, Turedi S, Cakir E, Yandi M. The prognostic value of neuron-specific enolase in head trauma patients. J Emerg Med. 2010;38(3):297–301.

    Article  PubMed  Google Scholar 

  10. González-García S, González-Quevedo A, Fernández-Concepción O, Peña-Sánchez M, Menéndez-Saínz C, Hernández-Díaz Z, et al. Short-term prognostic value of serum neuron specific enolase and S100B in acute stroke patients. Clin Biochem. 2012;45(16–17):1302–7.

    Article  PubMed  Google Scholar 

  11. Cronberg T, Rundgren M, Westhall E, Englund E, Siemund R, Rosén I, et al. Neuron-specific enolase correlates with other prognostic markers after cardiac arrest. Neurology. 2011;77(7):623–30.

    Article  CAS  PubMed  Google Scholar 

  12. Horn M, Seger F, Schlote W. Neuron-specific enolase in gerbil brain and serum after transient cerebral ischemia. Stroke J Cereb Circ. 1995;26(2):290–7.

    Article  CAS  Google Scholar 

  13. Gross J, Ungethüm U, Andreeva N, Heldt J, Priem F, Marschhausen G, et al. Glutamate-induced efflux of protein, neuron-specific enolase and lactate dehydrogenase from a mesencephalic cell culture. Eur J Clin Chem Clin Biochem J Forum Eur Clin Chem Soc. 1996;34(4):305–10.

    CAS  Google Scholar 

  14. Stroke-1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke. 1989;20(10):1407–31.

    Article  Google Scholar 

  15. WHO. 1999 Guidelines for management of hypertension [Internet]. Cited 2016 Jul 14.

  16. Brott T, Adams HP, Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke J Cereb Circ. 1989;20(7):864–70.

    Article  CAS  Google Scholar 

  17. Goldstein LB. Blood pressure management in patients with acute ischemic stroke. Hypertension. 2004;43(2):137–41.

    Article  CAS  PubMed  Google Scholar 

  18. Lisk DR, Grotta JC, Lamki LM, Tran HD, Taylor JW, Molony DA, et al. Should hypertension be treated after acute stroke? A randomized controlled trial using single photon emission computed tomography. Arch Neurol. 1993;50(8):855–62.

    Article  CAS  PubMed  Google Scholar 

  19. Casmiro M, Maitan S, De Pasquale F, Cova V, Scarpa E, Vignatelli L, et al. Cerebrospinal fluid and serum neuron-specific enolase concentrations in a normal population. Eur J Neurol. 2005;12(5):369–74.

    Article  CAS  PubMed  Google Scholar 

  20. de Leeuw F-E, de Groot JC, Oudkerk M, Witteman JCM, Hofman A, van Gijn J, et al. Hypertension and cerebral white matter lesions in a prospective cohort study. Brain J Neurol. 2002;125(Pt 4):765–72.

    Article  Google Scholar 

  21. Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31(7):1281–357.

    Article  CAS  PubMed  Google Scholar 

  22. Henskens LH, van Oostenbrugge RJ, Kroon AA, Hofman PA, Lodder J, de Leeuw PW. Detection of silent cerebrovascular disease refines risk stratification of hypertensive patients. J Hypertens. 2009;27(4):846–53.

    Article  CAS  PubMed  Google Scholar 

  23. Golstein P, Kroemer G. Cell death by necrosis: towards a molecular definition. Trends Biochem Sci. 2007;32(1):37–43.

    Article  CAS  PubMed  Google Scholar 

  24. González-Quevedo A, García SG, Concepción OF, Freixas RS, Sotolongo LQ, Menéndez MC, et al. Increased serum S-100B and neuron specific enolase—potential markers of early nervous system involvement in essential hypertension. Clin Biochem. 2011;44(2–3):154–9.

    Article  PubMed  Google Scholar 

  25. Johansson BB. Hypertension mechanisms causing stroke. Clin Exp Pharmacol Physiol. 1999;26(7):563–5.

    Article  CAS  PubMed  Google Scholar 

  26. González-Quevedo A, González-García S, Hernández-Díaz Z, Concepción OF, Sotolongo LQ, Peña-Sánchez M, et al. Serum neuron specific enolase could predict subclinical brain damage and the subsequent occurrence of brain related vascular events during follow up in essential hypertension. J Neurol Sci. 2016;363:158–63.

    Article  PubMed  Google Scholar 

  27. Yokobori S, Hosein K, Burks S, Sharma I, Gajavelli S, Bullock R. Biomarkers for the clinical differential diagnosis in traumatic brain injury—a systematic review. CNS Neurosci Ther. 2013;19(8):556–65.

    Article  CAS  PubMed  Google Scholar 

  28. Leonardi-Bee J, Bath PMW, Phillips SJ, Sandercock PAG, IST Collaborative Group. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke. 2002;33(5):1315–20.

    Article  PubMed  Google Scholar 

  29. Rodríguez-Yáñez M, Castellanos M, Blanco M, García MM, Nombela F, Serena J, et al. New-onset hypertension and inflammatory response/poor outcome in acute ischemic stroke. Neurology. 2006;67(11):1973–8.

    Article  PubMed  Google Scholar 

  30. Willmot M, Leonardi-Bee J, Bath PMW. High Blood Pressure in Acute Stroke and Subsequent Outcome. Hypertension. 2004;43(1):18–24.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anuradha Bharosay.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bharosay, A., Bharosay, V.V., Saxena, K. et al. Role of Brain Biomarker in Predicting Clinical Outcome in Hypertensive Cerebrovascular Ischemic Stroke. Ind J Clin Biochem 33, 178–183 (2018). https://doi.org/10.1007/s12291-017-0664-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12291-017-0664-3

Keywords

Navigation